Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk

Quest for biomarkers of treatment-resistant depression: shifting the paradigm toward risk

The search for potential biomarkers of psychiatric disorders is a central topic in biological psychiatry. This review concerns published studies on potential biomarkers of treatment-resistant depression (TRD). The search for biomarkers of TRD in the bloodstream has focused on cytokines and steroids...

Full description

Bibliographic Details
Main Author:	Donald F Smith
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2013-06-01
Series:	Frontiers in Psychiatry
Subjects:	Cytokines Immune System brain imaging biomarkers depressive disorders experimental design
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00057/full

Similar Items

Molecular Biomarkers for Pediatric Depressive Disorders: A Narrative Review
by: Jongha Lee, et al.
Published: (2021-09-01)

Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week study
by: Hashimoto T, et al.
Published: (2015-12-01)

The Association Between Shift Work and Immunological Biomarkers in Nurses
by: Bjørn Bjorvatn, et al.
Published: (2020-09-01)

Biomarkers of Post-COVID Depression
by: Piotr Lorkiewicz, et al.
Published: (2021-09-01)

Neuroinflammatory Basis of Depression: Learning From Experimental Models
by: Ruqayya Afridi, et al.
Published: (2021-07-01)

Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
by: Maria S. Simon, et al.
Published: (2021-09-01)

Bidirectional associations and common inflammatory biomarkers in COVID-19 and mental health disorders: A window of opportunity for future research?
by: Hugo Senra
Published: (2021-05-01)

Levels of serum immunomodulators and alterations with electroconvulsive therapy in treatment-resistant major depression
by: Zincir S, et al.
Published: (2016-06-01)

Lost in translation. The quest for definitions of treatment-resistant depression with a focus on inflammation-related gene expression
by: Luca Sforzini
Published: (2021-10-01)

Potential Biomarkers for Diagnosing Major Depressive Disorder Patients with Suicidal Ideation
by: Bai S, et al.
Published: (2021-02-01)

Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression
by: Sarah Kittel-Schneider, et al.
Published: (2020-04-01)

Editorial: Genetic Mechanisms of Biomarkers in Schizophrenia, Bipolar Disorder and Depression
by: Yiguo Tang, et al.
Published: (2021-08-01)

Brain SPECT perfusion and PET metabolism as discordant biomarkers in major depressive disorder
by: Maud Tastevin, et al.
Published: (2020-10-01)

The Role of Lipid Biomarkers in Major Depression
by: Amy Parekh, et al.
Published: (2017-02-01)

Extracellular Vesicle Biomarkers Reveal Inhibition of Neuroinflammation by Infliximab in Association with Antidepressant Response in Adults with Bipolar Depression
by: Rodrigo B. Mansur, et al.
Published: (2020-04-01)

Possibilities of using laboratory biomarkers for the objective diagnosis of depressive disorders
by: V. K. Shamrey, et al.
Published: (2021-04-01)

Immunological Interfaces: The COVID-19 Pandemic and Depression
by: Austin Perlmutter
Published: (2021-04-01)

Exploring Brain Derived Neurotrophic Factor and Cell Adhesion Molecules as Biomarkers for the Transdiagnostic Symptom Anhedonia in Alcohol Use Disorder and Comorbid Depression
by: Lyudmila A. Levchuk, et al.
Published: (2020-04-01)

A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol
by: Jennifer L. Phillips, et al.
Published: (2020-06-01)

Management of Treatment-Resistant Depression: Challenges and Strategies
by: Voineskos D, et al.
Published: (2020-01-01)

Depression and Obesity: Analysis of Common Biomarkers
by: Walter Milano, et al.
Published: (2020-06-01)

Brain-derived neurotrophic factor: a biomarker for obsessive-compulsive disorder?
by: Albino J Oliveira-Maia, et al.
Published: (2015-04-01)

Neuroimaging Biomarkers for Predicting Treatment Response and Recurrence of Major Depressive Disorder
by: Seung-Gul Kang, et al.
Published: (2020-03-01)

Study of Frontal Alpha Asymmetry in Mild Depression: A Potential Biomarker or Not?
by: Ambrish S. Dharmadhikari, et al.
Published: (2019-04-01)

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach
by: Hyebin Choi, et al.
Published: (2021-03-01)

Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive Disorder
by: Bai S, et al.
Published: (2021-08-01)

Phonologically-based biomarkers for major depressive disorder
by: Trevino Andrea, et al.
Published: (2011-01-01)

Poststroke Depression Biomarkers: A Narrative Review
by: Oleg A. Levada, et al.
Published: (2018-07-01)

Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major depressive disorder
by: Yachen Shi, et al.
Published: (2021-04-01)

Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study
by: Yuki Kageyama, et al.
Published: (2021-04-01)

Electroencephalographic Parameters Differentiating Melancholic Depression, Non-melancholic Depression, and Healthy Controls. A Systematic Review
by: Caroline Fussing Bruun, et al.
Published: (2021-08-01)

Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders
by: Suhyuk Chi, et al.
Published: (2021-02-01)

Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors
by: Jesper Geert Pedersen, et al.
Published: (2020-05-01)

Immune and hormonal activity in adults suffering from depression
by: S.O.V. Nunes, et al.
Published: (2002-05-01)

Salivary Biomarkers of Stress, Anxiety and Depression
by: Sylwia Chojnowska, et al.
Published: (2021-02-01)

Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision
by: Alice Pisoni, et al.
Published: (2018-08-01)

Th17 Cells in Depression: Are They Crucial for the Antidepressant Effect of Ketamine?
by: Meiying Cui, et al.
Published: (2021-04-01)

Search for biomarkers of asbestos exposure and asbestos-induced cancers in investigations of the immunological effects of asbestos
by: Hidenori Matsuzaki, et al.
Published: (2017-06-01)

Genetics Factors in Major Depression Disease
by: Maria Shadrina, et al.
Published: (2018-07-01)

Deep Brain Stimulation for Treatment-Resistant Depression: Towards a More Personalized Treatment Approach
by: Milaine Roet, et al.
Published: (2020-08-01)

Cannot write session to /tmp/vufind_sessions/sess_fm9i06vm9o45c8gran9taj2m2m